ABT-737 [Ligand Id: 8320] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL376408 (Abt 737, ABT-737)
  • BCL2 apoptosis regulator/Apoptosis regulator Bcl-2 in Human [ChEMBL: CHEMBL4860] [GtoPdb: 2844] [UniProtKB: P10415]
  • BCL2 apoptosis regulator/Apoptosis regulator Bcl-2 in Mouse [ChEMBL: CHEMBL3309111] [GtoPdb: 2844] [UniProtKB: P10417]
1 CHEMBL376408_lig_chart_1 Apoptosis regulator Bcl-2 HumanMouse
There should be some charts here, you may need to enable JavaScript!
  • Bcl-2-like 2/Apoptosis regulator Bcl-W in Human [ChEMBL: CHEMBL4677] [GtoPdb: 2846] [UniProtKB: Q92843]
2 CHEMBL376408_lig_chart_2 Apoptosis regulator Bcl-W Human
There should be some charts here, you may need to enable JavaScript!
  • Bcl-2-like 1/Apoptosis regulator Bcl-X in Human [ChEMBL: CHEMBL4625] [GtoPdb: 2845] [UniProtKB: Q07817]
3 CHEMBL376408_lig_chart_3 Apoptosis regulator Bcl-X Human
There should be some charts here, you may need to enable JavaScript!
  • Bcl2-antagonist of cell death (BAD) in Human [ChEMBL: CHEMBL3817] [UniProtKB: Q92934]
4 CHEMBL376408_lig_chart_4 Bcl2-antagonist of cell death (BAD) Human
There should be some charts here, you may need to enable JavaScript!
5 CHEMBL376408_lig_chart_5 Bcl-2-like 1 HumanMouse
There should be some charts here, you may need to enable JavaScript!
  • Bcl-2-like protein 10 in Human [ChEMBL: CHEMBL5988] [UniProtKB: Q9HD36]
  • This target only has 1 pki data point
6 CHEMBL376408_lig_chart_6 Bcl-2-like protein 10 Human
There should be some charts here, you may need to enable JavaScript!
  • Bcl-2-related protein A1 in Human [ChEMBL: CHEMBL6044] [UniProtKB: Q16548]
  • This target only has 1 pki data point
7 CHEMBL376408_lig_chart_7 Bcl-2-related protein A1 Human
There should be some charts here, you may need to enable JavaScript!
  • Beta-casein in Bovine [ChEMBL: CHEMBL3313833] [UniProtKB: P02666]
  • This target only has 1 pki data point
8 CHEMBL376408_lig_chart_8 Beta-casein Bovine
There should be some charts here, you may need to enable JavaScript!
  • MCL1 apoptosis regulator, BCL2 family member/Induced myeloid leukemia cell differentiation protein Mcl-1 in Human [ChEMBL: CHEMBL4361] [GtoPdb: 2847] [UniProtKB: Q07820]
9 CHEMBL376408_lig_chart_9 Induced myeloid leukemia cell differentiation protein Mcl-1 Human
There should be some charts here, you may need to enable JavaScript!
  • MCL1 apoptosis regulator, BCL2 family member/Induced myeloid leukemia cell differentiation protein Mcl-1 homolog in Mouse [ChEMBL: CHEMBL5768] [GtoPdb: 2847] [UniProtKB: P97287]
  • This target only has 0 pki data point
10 CHEMBL376408_lig_chart_10 Induced myeloid leukemia cell differentiation protein Mcl-1 homolog Mouse
There should be some charts here, you may need to enable JavaScript!
  • MCL1 apoptosis regulator, BCL2 family member/MCL1-BAK1 complex in Human [ChEMBL: CHEMBL3885523] [GtoPdb: 2847] [UniProtKB: Q07820Q16611]
  • This target only has 0 pki data point
11 CHEMBL376408_lig_chart_11 MCL1-BAK1 complex Human
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
BCL2 apoptosis regulator/Apoptosis regulator Bcl-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4860] [GtoPdb: 2844] [UniProtKB: P10415]
ChEMBL Binding affinity to Bcl-2 (unknown origin) by surface plasmon resonance analysis B 9.22 pKd 0.6 nM Kd ACS Med. Chem. Lett. (2013) 4: 186-190 [PMID:24900652]
ChEMBL Binding affinity to BCL2 (unknown origin) by fluorescence polarization assay B 6.92 pKi 120 nM Ki MedChemComm (2016) 7: 778-787
ChEMBL Binding affinity to BCl2 B 8.1 pKi 8 nM Ki J. Med. Chem. (2010) 53: 6779-6810 [PMID:20925433]
GtoPdb - - 9 pKi <1 nM Ki J. Med. Chem. (2007) 50: 641-62 [PMID:17256834]
ChEMBL Binding affinity to Bcl-2 by competitive fluorescence polarization assay B 9 pKi <1 nM Ki Bioorg. Med. Chem. Lett. (2012) 22: 39-44 [PMID:22172701]
ChEMBL Binding affinity to Bcl-2 B 9 pKi <1 nM Ki Eur. J. Med. Chem. (2012) 51: 286-293 [PMID:22425031]
ChEMBL Binding affinity to Bcl2 B 9 pKi <1 nM Ki Eur. J. Med. Chem. (2012) 57: 112-125 [PMID:23047228]
ChEMBL Binding affinity to Bcl-2 B 9 pKi <1 nM Ki J. Med. Chem. (2012) 55: 10735-10741 [PMID:23167494]
ChEMBL Binding affinity to Bcl-2 (unknown origin) fluorescence polarization assay B 9 pKi 1 nM Ki Bioorg. Med. Chem. (2013) 21: 11-20 [PMID:23206987]
ChEMBL Binding affinity to Bcl-2 (unknown origin) B 9 pKi <=1 nM Ki Bioorg. Med. Chem. (2014) 22: 4474-4489 [PMID:24811300]
ChEMBL Inhibition of Bcl2 (unknown origin) B 9 pKi <1 nM Ki J Med Chem (2018) 61: 2636-2651 [PMID:28926247]
ChEMBL Displacement of fluorescein labeled Bax peptide from Bcl2 by fluorescence polarization assay B 9 pKi <1 nM Ki J. Med. Chem. (2008) 51: 6902-6915 [PMID:18841882]
ChEMBL Displacement of Bax-derived peptide from Bcl2 by fluorescence polarization assay B 9 pKi <1 nM Ki J. Med. Chem. (2007) 50: 641-662 [PMID:17256834]
ChEMBL Inhibition of 5-FAM-Bid peptide binding to Bcl-2 (unknown origin) by fluorescence polarization assay B 9 pKi 1 nM Ki Bioorg Med Chem Lett (2016) 26: 5207-5211 [PMID:27712939]
ChEMBL Inhibition of Bcl-2 (unknown origin) B 9 pKi <1 nM Ki J Med Chem (2017) 60: 821-838 [PMID:27749061]
ChEMBL Binding affinity to N-terminus 6X His-tagged human Bcl2 expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay B 9.22 pKi <0.6 nM Ki J. Med. Chem. (2012) 55: 4664-4682 [PMID:22448988]
ChEMBL Inhibition of Bcl-2/biotinylated BAK (unknown origin) interaction incubated for 1 hr by surface plasmon resonance analysis B 7.7 pIC50 20 nM IC50 ACS Med. Chem. Lett. (2013) 4: 186-190 [PMID:24900652]
ChEMBL Binding affinity to Bcl-2 (unknown origin) by surface plasmon resonance assay B 8.15 pIC50 7 nM IC50 J. Med. Chem. (2013) 56: 5514-5540 [PMID:23767404]
ChEMBL Displacement of wild type mBimBH3 from human Bcl-2 by solution competition assay B 8.21 pIC50 6.1 nM IC50 J. Med. Chem. (2011) 54: 1914-1926 [PMID:21366295]
ChEMBL Binding affinity to N-terminus 6X His-tagged human Bcl2 expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay B 8.7 pIC50 2 nM IC50 J. Med. Chem. (2012) 55: 4664-4682 [PMID:22448988]
ChEMBL Inhibition of Bcl2 B 9 pIC50 <1 nM IC50 Bioorg. Med. Chem. (2012) 20: 4194-4200 [PMID:22739087]
ChEMBL Inhibition of cell growth in human SUDHL4 cells overexpressing Bcl2 in presence of 10% HS F 6.07 pEC50 850 nM EC50 J. Med. Chem. (2007) 50: 641-662 [PMID:17256834]
ChEMBL Inhibition of cell growth in human SUDHL4 cells overexpressing Bcl2 in presence of 3% FBS F 6.66 pEC50 220 nM EC50 J. Med. Chem. (2007) 50: 641-662 [PMID:17256834]
ChEMBL Inhibition of cell growth in human RS11380 cells overexpressing Bcl2 in presence of 10% HS F 6.82 pEC50 150 nM EC50 J. Med. Chem. (2007) 50: 641-662 [PMID:17256834]
ChEMBL Inhibition of cell growth in human DoHH2 cells overexpressing Bcl2 in presence of 10% HS F 6.89 pEC50 130 nM EC50 J. Med. Chem. (2007) 50: 641-662 [PMID:17256834]
ChEMBL Reversal of cytokine withdrawal protection in IL3 dependent Bcl2 overexpressing mouse FL5.12 cells in presence of 3% FBS F 7.3 pEC50 50 nM EC50 J. Med. Chem. (2007) 50: 641-662 [PMID:17256834]
ChEMBL Inhibition of GST-tagged recombinant Bcl2 interaction with biotinylated Bim peptide by ELISA based competitive binding assay B 7.52 pEC50 <30 nM EC50 Eur. J. Med. Chem. (2012) 57: 112-125 [PMID:23047228]
ChEMBL Inhibition of cell growth in human RS11380 cells overexpressing Bcl2 in presence of 3% FBS F 7.85 pEC50 14 nM EC50 J. Med. Chem. (2007) 50: 641-662 [PMID:17256834]
ChEMBL Inhibition of cell growth in human DoHH2 cells overexpressing Bcl2 in presence of 3% FBS F 8.08 pEC50 8.3 nM EC50 J. Med. Chem. (2007) 50: 641-662 [PMID:17256834]
ChEMBL Reversal of cytokine withdrawal protection in IL3 dependent Bcl2 overexpressing mouse FL5.12 cells in presence of bovine gelatin F 8.1 pEC50 8 nM EC50 J. Med. Chem. (2007) 50: 641-662 [PMID:17256834]
BCL2 apoptosis regulator/Apoptosis regulator Bcl-2 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3309111] [GtoPdb: 2844] [UniProtKB: P10417]
ChEMBL Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The inhibition constant (Ki) is the dissociation constant of an enzyme-inhibitor complex or a protein/small molecule complex, wherein the small molecule is inhibiting binding of one protein to another protein or peptide. Where the Ki for a compound is represented as > (greater than) a certain numerical value, it is intended to mean that the binding affinity value (e.g., for Bcl-XL) is greater than the limits of detection of the assay used. Where the binding selectivity ratio for a compound is represented as > (greater than) a certain numerical value, it is intended to mean that the selectivity of a particular compound for Bcl-2 over Bcl-XL is at least as great as the number indicated. Where the Ki for a compound is represented as < (less than) a certain numerical value, it is intended to mean that the binding affinity value (e.g., for Bcl-2) is lower than the limit of detection of the assay used. Inhibition constants were determined using Wang's equation (Wang Z-X). B 10.06 pKi 0.09 nM Ki US-9125913-B2. Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2015)
Bcl-2-like 2/Apoptosis regulator Bcl-W in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4677] [GtoPdb: 2846] [UniProtKB: Q92843]
GtoPdb - - 9 pKi <1 nM Ki J. Med. Chem. (2007) 50: 641-62 [PMID:17256834]
ChEMBL Binding affinity to Bcl-w B 9 pKi <1 nM Ki Eur. J. Med. Chem. (2012) 57: 112-125 [PMID:23047228]
ChEMBL Binding affinity to Bcl-w (unknown origin) B 9 pKi <=1 nM Ki Bioorg. Med. Chem. (2014) 22: 4474-4489 [PMID:24811300]
ChEMBL Inhibition of Bcl-w (unknown origin) B 9 pKi <1 nM Ki J Med Chem (2017) 60: 821-838 [PMID:27749061]
ChEMBL Binding affinity to Bcl-w (unknown origin) by surface plasmon resonance assay B 7.18 pIC50 66 nM IC50 J. Med. Chem. (2013) 56: 5514-5540 [PMID:23767404]
ChEMBL Displacement of wild type mBimBH3 from human Bcl-w by solution competition assay B 7.4 pIC50 40 nM IC50 J. Med. Chem. (2011) 54: 1914-1926 [PMID:21366295]
ChEMBL Inhibition of Bcl-w B 9 pIC50 <1 nM IC50 Bioorg. Med. Chem. (2012) 20: 4194-4200 [PMID:22739087]
Bcl-2-like 1/Apoptosis regulator Bcl-X in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4625] [GtoPdb: 2845] [UniProtKB: Q07817]
ChEMBL Binding affinity to Bcl-Xl B 9.43 pKd 0.37 nM Kd J. Med. Chem. (2011) 54: 1914-1926 [PMID:21366295]
ChEMBL Binding affinity to human GST-tagged Bcl-Xl assessed as dissociation rate by surface plasmon resonance assay B 9.89 pKd 0.13 nM Kd J. Med. Chem. (2013) 56: 5514-5540 [PMID:23767404]
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 Y101H mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 6.42 pKi 380 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 F97V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 6.52 pKi 300 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 6.54 pKi 290 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142T mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 6.57 pKi 270 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 V141A mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 6.72 pKi 190 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Inhibition of recombinant His6-tagged Bcl-XL expressed in Escherichia coli BL21 (DE3) and Flu-Bak peptide interaction by fluorescence polarization assay B 6.72 pKi 188.4 nM Ki J. Med. Chem. (2009) 52: 5937-5949 [PMID:19743858]
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 R100E mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 6.8 pKi 160 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130A mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 7.14 pKi 73 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Binding affinity to Bcl-XL (unknown origin) by fluorescence polarization assay B 7.19 pKi 64 nM Ki MedChemComm (2016) 7: 778-787
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 L130V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 7.24 pKi 58 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Binding affinity to Bcl-xl B 7.52 pKi 30 nM Ki J. Med. Chem. (2010) 53: 6779-6810 [PMID:20925433]
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 7.68 pKi 21 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 E96G mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 8.24 pKi 5.8 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 E129H mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 8.35 pKi 4.5 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Wild type Bcl-2-like protein 1 expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 8.47 pKi 3.4 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 Y195F mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 8.82 pKi 1.5 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A93V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 8.85 pKi 1.4 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Inhibition of Bcl-xL (unknown origin) B 9 pKi <1 nM Ki J Med Chem (2018) 61: 2636-2651 [PMID:28926247]
ChEMBL Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 G196A mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay B 9 pKi <1 nM Ki Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Binding affinity to Bcl-xL by competitive fluorescence polarization assay B 9 pKi <1 nM Ki Bioorg. Med. Chem. Lett. (2012) 22: 39-44 [PMID:22172701]
ChEMBL Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay B 9 pKi <1 nM Ki J. Med. Chem. (2012) 55: 4664-4682 [PMID:22448988]
ChEMBL Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay B 9 pKi <1 nM Ki J. Med. Chem. (2012) 55: 6149-6161 [PMID:22747598]
ChEMBL Binding affinity to Bcl-XL B 9 pKi <1 nM Ki Eur. J. Med. Chem. (2012) 57: 112-125 [PMID:23047228]
ChEMBL Binding affinity to Bcl-XL B 9 pKi <1 nM Ki J. Med. Chem. (2012) 55: 10735-10741 [PMID:23167494]
ChEMBL Displacement of fluorescein-labeled BAK from His-tagged BCL-XL (unknown origin) after 1 hr by fluorescence polarization assay B 9 pKi <1 nM Ki J. Nat. Prod. (2014) 77: 1430-1437 [PMID:24901800]
ChEMBL Inhibition of 5-FAM-Bid peptide binding to Bcl-XL (unknown origin) by fluorescence polarization assay B 9 pKi 1 nM Ki Bioorg Med Chem Lett (2016) 26: 5207-5211 [PMID:27712939]
ChEMBL Inhibition of Bcl-xL (unknown origin) B 9 pKi <1 nM Ki J Med Chem (2017) 60: 821-838 [PMID:27749061]
ChEMBL Binding affinity to Bcl-xL (unknown origin) B 9 pKi <=1 nM Ki Bioorg. Med. Chem. (2014) 22: 4474-4489 [PMID:24811300]
GtoPdb - - 9.3 pKi <0.5 nM Ki J. Med. Chem. (2007) 50: 641-62 [PMID:17256834]
ChEMBL Binding affinity to human GST-tagged Bcl-Xl by fluorescence polarization assay B 9.3 pKi <0.5 nM Ki J. Med. Chem. (2013) 56: 5514-5540 [PMID:23767404]
ChEMBL Binding affinity to Bcl-xL B 9.3 pKi <0.5 nM Ki Eur. J. Med. Chem. (2012) 51: 286-293 [PMID:22425031]
ChEMBL Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay B 9.3 pKi <0.5 nM Ki J. Med. Chem. (2007) 50: 641-662 [PMID:17256834]
ChEMBL Inhibition of Bcl-xL B 7.19 pIC50 64 nM IC50 J. Med. Chem. (2010) 53: 2577-2588 [PMID:20192224]
ChEMBL Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum B 7.22 pIC50 <60 nM IC50 J. Med. Chem. (2007) 50: 641-662 [PMID:17256834]
ChEMBL Binding affinity to human GST-tagged Bcl-Xl by surface plasmon resonance assay B 7.85 pIC50 14 nM IC50 J. Med. Chem. (2013) 56: 5514-5540 [PMID:23767404]
ChEMBL Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay B 8.22 pIC50 6 nM IC50 Bioorg. Med. Chem. (2015) 23: 1747-1757 [PMID:25797160]
ChEMBL Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay B 8.22 pIC50 6 nM IC50 J. Med. Chem. (2012) 55: 4664-4682 [PMID:22448988]
ChEMBL Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay B 8.22 pIC50 6 nM IC50 J. Med. Chem. (2012) 55: 6149-6161 [PMID:22747598]
ChEMBL Displacement of biotinylated Bim-BH3 from GST-tagged Bcl-Xl by AlphaScreen competitive assay B 8.52 pIC50 3 nM IC50 J. Med. Chem. (2011) 54: 1914-1926 [PMID:21366295]
ChEMBL Inhibition of Bcl-XL B 9 pIC50 <1 nM IC50 Bioorg. Med. Chem. (2012) 20: 4194-4200 [PMID:22739087]
ChEMBL Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay B 9.3 pIC50 0.5 nM IC50 J. Med. Chem. (2013) 56: 5514-5540 [PMID:23767404]
ChEMBL Reversal of cytokine withdrawal protection in IL3 dependent Bcl-xL overexpressing mouse FL5.12 cells in presence of bovine gelatin F 7.52 pEC50 30 nM EC50 J. Med. Chem. (2007) 50: 641-662 [PMID:17256834]
ChEMBL Inhibition of Bcl-XL B 7.52 pEC50 29.99 nM EC50 Eur. J. Med. Chem. (2010) 45: 4774-4782 [PMID:20728251]
ChEMBL Inhibition of GST-tagged recombinant Bcl-XL interaction with biotinylated Bim peptide by ELISA based competitive binding assay B 8 pEC50 <10 nM EC50 Eur. J. Med. Chem. (2012) 57: 112-125 [PMID:23047228]
Bcl2-antagonist of cell death (BAD) in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3817] [UniProtKB: Q92934]
ChEMBL Displacement of fluorescein labeled BAD peptide from Bcl-XL by fluorescence polarization assay B 9 pKi <1 nM Ki J. Med. Chem. (2008) 51: 6902-6915 [PMID:18841882]
ChEMBL Binding affinity to Bcl-XL assessed as inhibition of Bcl-XL-BAD derived peptide interaction B 9.22 pKi 0.6 nM Ki Nature (2007) 450: 1001-1009 [PMID:18075579]
Bcl-2-like 1 in Human [GtoPdb: 2845] [UniProtKB: Q07817]
GtoPdb - - 9.3 pKi <0.5 nM Ki J. Med. Chem. (2007) 50: 641-62 [PMID:17256834]
Bcl-2-like 1/Bcl-2-like protein 1 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3309112] [GtoPdb: 2845] [UniProtKB: Q64373]
ChEMBL Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The inhibition constant (Ki) is the dissociation constant of an enzyme-inhibitor complex or a protein/small molecule complex, wherein the small molecule is inhibiting binding of one protein to another protein or peptide. Where the Ki for a compound is represented as > (greater than) a certain numerical value, it is intended to mean that the binding affinity value (e.g., for Bcl-XL) is greater than the limits of detection of the assay used. Where the binding selectivity ratio for a compound is represented as > (greater than) a certain numerical value, it is intended to mean that the selectivity of a particular compound for Bcl-2 over Bcl-XL is at least as great as the number indicated. Where the Ki for a compound is represented as < (less than) a certain numerical value, it is intended to mean that the binding affinity value (e.g., for Bcl-2) is lower than the limit of detection of the assay used. Inhibition constants were determined using Wang's equation (Wang Z-X). B 10.1 pKi 0.08 nM Ki US-9125913-B2. Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2015)
Bcl-2-like protein 10 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5988] [UniProtKB: Q9HD36]
ChEMBL Binding affinity to Bcl-b (unknown origin) B 9 pKi >1 nM Ki Bioorg. Med. Chem. (2014) 22: 4474-4489 [PMID:24811300]
Bcl-2-related protein A1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6044] [UniProtKB: Q16548]
ChEMBL Binding affinity for GST-tagged human BCL2A1 expressed in Escherichia coli BL21 cells B 6 pKd >1000 nM Kd Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
ChEMBL Binding affinity to Bcl2A1 (unknown origin) B 4.7 pKi >20000 nM Ki J Med Chem (2017) 60: 821-838 [PMID:27749061]
Beta-casein in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3313833] [UniProtKB: P02666]
ChEMBL Binding affinity to bovine beta-casein A1 B 9 pKi >1 nM Ki Bioorg. Med. Chem. (2014) 22: 4474-4489 [PMID:24811300]
MCL1 apoptosis regulator, BCL2 family member/Induced myeloid leukemia cell differentiation protein Mcl-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4361] [GtoPdb: 2847] [UniProtKB: Q07820]
ChEMBL Binding affinity to Mcl-1 by competitive fluorescence polarization assay B 4 pKi >100000 nM Ki Bioorg. Med. Chem. Lett. (2012) 22: 39-44 [PMID:22172701]
ChEMBL Displacement of fluorescein-labeled BID from His-tagged MCL-1 (unknown origin) after 1 hr by fluorescence polarization assay B 4.68 pKi 20800 nM Ki J. Nat. Prod. (2014) 77: 1430-1437 [PMID:24901800]
ChEMBL Binding affinity to Mcl-1 B 4.7 pKi >20000 nM Ki Eur. J. Med. Chem. (2012) 51: 286-293 [PMID:22425031]
ChEMBL Inhibition of 5-FAM-Bid peptide binding to MCL-1 (unknown origin) by fluorescence polarization assay B 4.7 pKi >20000 nM Ki Bioorg Med Chem Lett (2016) 26: 5207-5211 [PMID:27712939]
ChEMBL Binding affinity to Mcl-1 (unknown origin) B 4.7 pKi >20000 nM Ki J Med Chem (2017) 60: 821-838 [PMID:27749061]
ChEMBL Binding affinity to induced myeloid leukemia cell differentiation protein 1 (unknown origin) B 9 pKi >1 nM Ki Bioorg. Med. Chem. (2014) 22: 4474-4489 [PMID:24811300]
ChEMBL Displacement of wild type mBimBH3 from Mcl-1 by solution competition assay B 6 pIC50 >1000 nM IC50 J. Med. Chem. (2011) 54: 1914-1926 [PMID:21366295]
ChEMBL Binding affinity to N-terminus 8X His-tagged human Mcl1 expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay B 6 pIC50 >1000 nM IC50 J. Med. Chem. (2012) 55: 4664-4682 [PMID:22448988]
ChEMBL Inhibition of human N-terminal His8-tagged Mcl1 expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BID binding after 1 to 2 hrs by fluorescence polarization assay B 6 pIC50 >1000 nM IC50 J. Med. Chem. (2012) 55: 6149-6161 [PMID:22747598]
ChEMBL Binding affinity to MCL1 (unknown origin) by fluorescence polarization assay B 6 pIC50 >1000 nM IC50 MedChemComm (2016) 7: 778-787
MCL1 apoptosis regulator, BCL2 family member/Induced myeloid leukemia cell differentiation protein Mcl-1 homolog in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5768] [GtoPdb: 2847] [UniProtKB: P97287]
ChEMBL Binding affinity for GST-tagged mouse MCL1 expressed in Escherichia coli BL21 cells B 6 pKd >1000 nM Kd Bioorg. Med. Chem. Lett. (2011) 21: 4951-4955 [PMID:21807512]
MCL1 apoptosis regulator, BCL2 family member/MCL1-BAK1 complex in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3885523] [GtoPdb: 2847] [UniProtKB: Q07820Q16611]
ChEMBL Inhibition of Mcl1-BAK interaction B 4.3 pIC50 >50000 nM IC50 ACS Med. Chem. Lett. (2012) 3: 579-583 [PMID:24900514]

ChEMBL data shown on this page come from version 27:

Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, CibriƔn-Uhalte E, Davies M, Dedman N, Karlsson A, MagariƱos MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]